Riskpilot← Back to searchSign inGet full accessVITREX MEDICAL A/S
A/SActiveCVR 14728732Vasekær 6-8Manufacture and processing of other glass, including technical glassware · NACE 2315Est. 199058 employees
Revenue 2025
DKK 34,7M
+20% vs 2024
EBITDA margin
35.2%
+119% vs 2024
Equity ratio
66.1%
Financial strength
Net profit 2025
DKK 6,2M
+240% vs 2024
| Revenue | DKK 34,7M | +20% |
| EBITDA | DKK 12,2M | +119% |
| Net profit | DKK 6,2M | +240% |
| Total assets | DKK 63,9M | -3% |
| Equity | DKK 42,2M | +17% |
| Employees | 58 | — |
Legal name
VITREX MEDICAL A/S
CVR number
14728732
Legal form
Aktieselskab
NACE code
2315 · Manufacture and processing of other glass, including technical glassware
Founded
1. november 1990
Share capital
DKK 2.251.698
Employees
58 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af et bestyrelsesmedlem i forening med en direktør, af bestyrelsesformanden alene eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at drive virksomhed med fabrikation, industri og handel, herunder med køb og salg af værdipapirer.
Address
Vasekær 6-8
Phone
+4544947011
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -13.775 | 14.668 | 16.035 | 12.703 | 21.234 | 20.604 | 22.491 | 25.131 | 21.576 | 25.915 | 28.623 | 26.583 | 28.139 | 28.937 | 34.669 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -33.206 | -34.192 | -31.799 |
| EBITDA | -5.525 | 5.783 | 6.288 | 5.922 | 7.943 | 6.799 | 7.685 | 10.978 | 5.436 | 9.516 | 9.555 | 7.833 | 5.115 | 5.566 | 12.207 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -2.317 | -2.860 | -2.652 | -3.002 | -3.057 |
| EBIT | -5.525 | 5.783 | 6.288 | 5.922 | 7.943 | 6.799 | 7.685 | 10.978 | 5.436 | 9.516 | 7.237 | 4.973 | 2.463 | 2.564 | 9.149 |
| Net financials | -872 | -609 | -343 | 57 | 12 | -286 | 534 | 201 | -56 | 225 | -152 | 330 | -879 | -218 | -1.073 |
| Profit before tax | -4.899 | 5.174 | 5.948 | 5.979 | 7.955 | 6.513 | 8.219 | 11.179 | 5.380 | 9.742 | 7.086 | 5.304 | 1.584 | 2.346 | 8.077 |
| Tax | -1.230 | 1.292 | 1.336 | 1.456 | 1.752 | 1.435 | 1.818 | 2.482 | 1.262 | 2.163 | 1.584 | 1.251 | 369 | 527 | 1.897 |
| Net profit | -3.669 | 3.882 | 4.611 | 4.524 | 6.203 | 5.078 | 6.400 | 8.696 | 4.117 | 7.579 | 5.502 | 4.053 | 1.215 | 1.819 | 6.180 |
| Item | 2012 | 2013 | 2014 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 28.039 | 30.464 | 32.107 | 31.102 | 35.589 | 38.942 | 39.812 | 44.261 | 40.819 | 50.533 | 53.651 | 65.731 | 60.114 | 65.869 | 63.892 |
| Equity | 10.388 | 13.270 | 17.881 | 18.405 | 20.607 | 20.685 | 22.086 | 25.782 | 24.900 | 31.478 | 31.980 | 33.033 | 34.248 | 36.067 | 42.247 |
| Long-term debt | -6.241 | 5.231 | 3.306 | 1.783 | 1.366 | 942 | 519 | 94 | 394 | 1.117 | 835 | 2.599 | 4.467 | 3.617 | 2.320 |
| Short-term debt | -9.912 | 9.922 | 8.996 | 8.811 | 11.702 | 15.464 | 15.147 | 16.195 | 12.924 | 15.402 | 18.054 | 26.945 | 18.048 | 22.913 | 15.795 |
| Total debt | -16.153 | 15.154 | 12.302 | 10.594 | 13.067 | 16.406 | 15.665 | 16.289 | 13.318 | 16.519 | 18.889 | 29.543 | 22.516 | 26.530 | 18.115 |
EBITDA margin
35.2%
This company
15.8%
Market median
+123% vs market
20122025
Equity ratio
66.1%
This company
38.2%
Market median
+73% vs market
20122025
Return on equity
14.6%
This company
18.4%
Market median
+21% vs market
20122025
Net profit margin
17.8%
This company
8.1%
Market median
+120% vs market
20122025
Asset turnover
0.54×
This company
1.12×
Market median
-52% vs market
20122025
Debt / equity
0.51×
This company
0.62×
Market median
+18% vs market
20122025
- Annual report 2025Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-05-01 – 2014-12-31
- Annual report 2014Filed via CVR / Virk · Period 2013-05-01 – 2014-04-30
- Annual report 2013Filed via CVR / Virk · Period 2012-05-01 – 2013-04-30
- Annual report 2012Filed via CVR / Virk · Period 2011-05-01 – 2012-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SH Audit | Audit | 1990 | — | — |
AF Chief Executive Officer | Chief Executive Officer | 2017 | — | — |
ET | Audit | 1990 | — | — |
BA Audit | Audit | 1998 | — | — |
BS Management | Management | 2010 | — | — |
PE Management | Management | 1990 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2017 | — | — | |
| Board of Directors | 2023 | — | — | |
| Board of Directors | 1990 | — | — | |
| Board of Directors | 1990 | — | — | |
| Board of Directors | 1990 | — | — | |
| Board of Directors | 2002 | — | — | |
| Chairman | 2014 | — | — | |
| Board of Directors | 2014 | — | — | |
| Board of Directors | 2008 | — | — | |
| Board of Directors | 2014 | — | — | |
| Chairman | 1990 | — | — | |
| Chairman | 2004 | — | — | |
| Board of Directors | 2002 | — | — | |
| Board of Directors | 2002 | — | — | |
| Board of Directors | 1990 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2014 | |
| Individual | 25.0% | 25.0% | 2014 | |
| Individual | 25.0% | 25.0% | 2014 | |
| Individual | 25.0% | 25.0% | 2014 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of VITREX MEDICAL A/S also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sven Halberg | Audit | 0 companies |
| Anders Folkmar Pedersen | Chief Executive Officer | 0 companies |
| Erik Tronborg Andersen | Audit | 0 companies |
| Bjarne Albrechtsen | Audit | 0 companies |
| Børge Stentoft | Management | 0 companies |
| Per Emil Hasselbalch Stakemann | Management | 0 companies |
| Vagn Andersen | Board of Directors | 0 companies |
| Marcin Sieczek | Board of Directors | 0 companies |
| Ulf Svejgaard Poulsen | Board of Directors | 0 companies |
| Inge Fasting | Board of Directors | 0 companies |
| Kaj Julius Hviid-Nielsen | Board of Directors | 0 companies |
| Ditte Valentin Meincke | Board of Directors | 0 companies |
| Michal Staron | Chairman | 0 companies |
| Marek Herold | Board of Directors | 0 companies |
| Per Hugo Thomsen | Board of Directors | 0 companies |
| Teodor Lysák | Board of Directors | 0 companies |
| Susanne Saul Stakemann | Chairman | 0 companies |
| Max Krasnik | Chairman | 0 companies |
| Søren Valentin Stentoft | Board of Directors | 0 companies |
| Fatima Zahra Susanne Hammadi | Board of Directors | 0 companies |
| Jørgen Gunnar Jørgensen | Board of Directors | 0 companies |